Cargando…

High mobility group box 1 is a novel deacetylation target of Sirtuin1

High mobility group box 1 (HMGB1) undergoes acetylation, nuclear-to-cytoplasmic translocation and release from stressed kidneys, unleashing a signaling cascade of events leading to systemic inflammation. Here we tested whether the deacetylase activity of Sirtuin1 (SIRT1) participates in regulating n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rabadi, May M., Xavier, Sandhya, Vasko, Radovan, Kaur, Kavneet, Goligorksy, Michael S., Ratliff, Brian B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270955/ https://www.ncbi.nlm.nih.gov/pubmed/24940804 http://dx.doi.org/10.1038/ki.2014.217

Ejemplares similares

Sirtuin1-Mediated Deacetylation of Hypothalamic TTF-1 Contributes to the Energy Deficiency Response
por: Kang, Dasol, et al.
Publicado: (2023)

Regulation of Sirtuin-Mediated Protein Deacetylation by Cardioprotective Phytochemicals
por: Treviño-Saldaña, Niria, et al.
Publicado: (2017)

Ubiquitin-specific protease 3 attenuates interleukin-1β-mediated chondrocyte senescence by deacetylating forkhead box O-3 via sirtuin-3
por: Zhou, Qi, et al.
Publicado: (2022)

Activation of Sirtuin 1 Attenuates High Glucose-Induced Neuronal Apoptosis by Deacetylating p53
por: Shi, Xiajie, et al.
Publicado: (2018)

Deacetylation of XBP1s by sirtuin 6 confers resistance to ER stress-induced hepatic steatosis
por: Bang, In Hyuk, et al.
Publicado: (2019)

Sirtuin 2 aggravates postischemic liver injury by deacetylating mitogen‐activated protein kinase phosphatase‐1
por: Wang, Jie, et al.
Publicado: (2016)

Charting the course of renal cryoinjury
por: Abdulmahdi, Wasan, et al.
Publicado: (2015)

High-mobility group box 1: role in ARDS
por: Ishizaka, A, et al.
Publicado: (2005)

High‐Mobility Group Box‐1 and Liver Disease
por: Gaskell, Harriet, et al.
Publicado: (2018)

High mobility group box 1 in diabetic nephropathy
por: Shi, Haitao, et al.
Publicado: (2017)

High Mobility Group Box 1 in Human Cancer
por: Rapoport, Bernardo L., et al.
Publicado: (2020)

High Mobility Group Box 1 (HMGB1): Potential Target in Sepsis-Associated Encephalopathy
por: DeWulf, Bram, et al.
Publicado: (2023)

Resveratrol Reduced Liver Damage After Liver Resection in a Rat Model by Upregulating Sirtuin 1 (SIRT1) and Inhibiting the Acetylation of High Mobility Group Box 1 (HMGB1)
por: Yu, Sheng, et al.
Publicado: (2019)

TRPV1 Activation Counters Diet-Induced Obesity Through Sirtuin-1 activation and PRDM-16 Deacetylation in Brown Adipose Tissue
por: Baskaran, Padmamalini, et al.
Publicado: (2017)

Sirtuin 1-dependent regulation of high mobility box 1 in hypoxia–reoxygenated brain microvascular endothelial cells: roles in neuronal amyloidogenesis
por: Lee, Young-Sun, et al.
Publicado: (2020)

Targeting High Mobility Group Box 1 in Subarachnoid Hemorrhage: A Systematic Review
por: Muhammad, Sajjad, et al.
Publicado: (2020)

High mobility group box-1: a potential therapeutic target for allergic rhinitis
por: Wu, Shuhua, et al.
Publicado: (2023)

Electroacupuncture Regulates Inguinal White Adipose Tissue Browning by Promoting Sirtuin-1-Dependent PPARγ Deacetylation and Mitochondrial Biogenesis
por: Tang, Qianqian, et al.
Publicado: (2021)

Sirtuin 1 in Chronic Kidney Disease and Therapeutic Potential of Targeting Sirtuin 1
por: Yan, Jiayi, et al.
Publicado: (2022)

HMGB1 redox during sepsis
por: Abdulmahdi, Wasan, et al.
Publicado: (2017)

High mobility group box 1: as a 'testament' mediator
por: Maruyama, I, et al.
Publicado: (2005)

The Role of High Mobility Group Box 1 in Innate Immunity
por: Lee, Shin-Ae, et al.
Publicado: (2014)

High Mobility Group Box Protein-1 in Wound Repair
por: Ranzato, Elia, et al.
Publicado: (2012)

High-Mobility Group Box 1 in Dry Eye Inflammation
por: Lema, Carolina, et al.
Publicado: (2018)

The Role of High Mobility Group Box 1 in Ischemic Stroke
por: Ye, Yingze, et al.
Publicado: (2019)

Role of High-Mobility Group Box-1 in Liver Pathogenesis
por: Khambu, Bilon, et al.
Publicado: (2019)

High Mobility Group Box 1 Protein in Cerebral Thromboemboli
por: Essig, Fabian, et al.
Publicado: (2021)

Urinary and serum levels of high mobility group box 1
por: Nakamura, Toshihiko, et al.
Publicado: (2023)

Melatonin Lowers HIF-1α Content in Human Proximal Tubular Cells (HK-2) Due to Preventing Its Deacetylation by Sirtuin 1
por: Owczarek, Aleksandra, et al.
Publicado: (2021)

High-mobility group box 1 protein, angiotensins, ACE2, and target organ damage
por: Luft, Friedrich C.
Publicado: (2015)

Role of Extracellular High-Mobility Group Box-1 as a Therapeutic Target of Gastric Cancer
por: Takaki, Wataru, et al.
Publicado: (2022)

Sirtuin 2 Prevents Liver Steatosis and Metabolic Disorders by Deacetylation of Hepatocyte Nuclear Factor 4α
por: Ren, Huihui, et al.
Publicado: (2021)

The role of High Mobility Group Box 1 (HMGB1) in colorectal cancer
por: Süren, Dinç, et al.
Publicado: (2014)

Sirtuin 1 Induces Choroidal Neovascularization and Triggers Age-Related Macular Degeneration by Promoting LCN2 through SOX9 Deacetylation
por: Zhao, Su, et al.
Publicado: (2022)

Clinical judgment is the most important element in overhydration assessment of chronic hemodialysis patients
por: Vasko, Radovan, et al.
Publicado: (2012)

Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy
por: Walker, Lauren Elizabeth, et al.
Publicado: (2017)

Identification and Characterization of the Lamprey High-Mobility Group Box 1 Gene
por: Pang, Yue, et al.
Publicado: (2012)

Expression and Effects of High-Mobility Group Box 1 in Cervical Cancer
por: Pang, Xiaoao, et al.
Publicado: (2014)

High Mobility Group Box 1 Expression in Oral Inflammation and Regeneration
por: Yamashiro, Keisuke, et al.
Publicado: (2020)

High Mobility Group Box-1 and Blood–Brain Barrier Disruption
por: Nishibori, Masahiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d9bnj1i7k867mc9ms2ps47v5ti